Solenic Medical Treats First Patient in Early Feasibility Clinical Trial
Solenic Medical Inc., a medical device innovator developing non-invasive treatments for infected metallic implants, has reached a major milestone: the successful treatment of its first patient in an early feasibility clinical trial using its investigational Alternating Magnetic Field (AMF) technology. This achievement represents years of research aimed at addressing challenging implant-associated infections, especially prosthetic joint infections (PJIs). Solenic’s patented AMF technology uses targeted heat to eliminate biofilms on implant surfaces, without surgery, and is designed to work alongside standard antibiotic treatments.
Solenic Medical Treats First Patient in Early Feasibility Clinical Trial